Cortistatin-A |
Cortistatin-A : Inhibitor of CDK19, CDK8
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK19 |
|
|
| CDK8 |
|
|
Inhibitor
1-1000 nM, 100 nM provides full inhibition of CDK8 and CDK19 in cells
Selectivity
In Vitro Selectivity Assessment
Potency: IC50
Potency Assay Off-Target:
In vitro kinase assay and Kinativ cell lysate displacement assay.
Selectivity Assessment Description:
No reproducible off-targets were validated up to 1 uM Cortistatin A. The only kinase affected in th ...
Potency Cellular
In Vitro
CDK19
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/nature14904
CDK8
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/nature14904
In Vivo Validations
Mouse
Dose: 1 mg/kg (PK study), 0.16 mg/kg once-daily (efficacy study)
Route of delivery:
Intraperitoneal
Plasma half life:
12.7 hours (PK study)
Systemic clearance:
20 mL/min/kg (CL/F) (PK study)
Target engagement assay:
Target engagement was indirectly determined by measuring a dose-dependent reduction in levels of STAT1-pS727 in natural killer cells.
DOI Reference: 10.1038/nature14904
Orthogonal Probes def
CCT251545
Chemical Information
| Molecular Formula | C30H36N2O3 |
| SMILEs | CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@@H]42)C=C3[C@@H](O)[C@@H]1O |
| InChI | InChI=1S/C30H36N2O3/c1-28-10-8-21-15-23-26(33)27(34)24(32(2)3)16-29(23)11-12-30(21,35-29)25(28)7-6-22(28)19-5-4-18-9-13-31-17-20(18)14-19/h4-5,8-9,13-15,17,22,24-27,33-34H,6-7,10-12,16H2,1-3H3/t22-,24+,25-,26-,27-,28-,29-,30-/m1/s1 |
| Molecular weight | 472.27 Da |
| AlogP | 0.0 |
| HBond acceptors | 5 |
| HBond donors | 2 |
| Atoms | 71 |